Avrobio Inc reported $243.58M in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Akebia Therapeutics AKBA:US $ 502.67M 104.17M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Applied Genetic Technologies AGTC:US $ 129.01M 38.16M
Bluebird Bio BLUE:US $ 1.29B 865.55M
Epizyme EPZM:US $ 523.52M 323.9M
Gilead Sciences GILD:US $ 87.58B 1.22B
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Karyopharm Therapeutics KPTI:US $ 439.39M 335.56M
Macrogenics MGNX:US $ 1.28B 335.6M
Pfizer PFE:US $ 241143.67M 21937.97M
Sangamo Biosciences SGMO:US $ 1.31B 412.77M
Sanofi SAN:FP 104.97B 6.43B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Takeda 4502:JP 5852.75B 17.24B